24.39

0.21% 0.05

Pacira Biosciences Inc (PCRX)

Overview News Price History Option Chain Financials Discussions Forecast

Pacira Biosciences Inc stock is traded at $24.39, with a volume of 351.37K. It is up +0.21% in the last 24 hours and down -5.68% over the past month. Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Previous Close:

$24.34

Open:

$24.32

24h Volume:

351.37K

Relative Volume:

0.41

Market Cap:

$1.15B

Revenue:

$681.75M

Net Income/Loss:

$70.47M

P/E Ratio:

16.82

EPS:

1.45

Net Cash Flow:

$173.19M

1W Performance:

-1.93%

1M Performance:

-5.68%

6M Performance:

+23.00%

1Y Performance:

-10.79%

1-Day Range:

$24.03

$24.90

1-Week Range:

$23.50

$25.16

52-Week Range:

$11.16

$29.61

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name

Pacira Biosciences Inc

Sector

Healthcare (1172)

Industry

Drug Manufacturers - Specialty & Generic (82)

Phone

650-242-8052

Address

2000 SIERRA POINT PARKWAY, BRISBANE, NJ

Employee

790

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

PCRX's Discussions on Twitter

Compare PCRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PCRX Pacira Biosciences Inc	24.39	1.15B	681.75M	70.47M	173.19M	1.45
RGC Regencell Bioscience Holdings Ltd	78.00	303.95B	0	-5.87M	-767.30K	-0.45
ZTS Zoetis Inc	161.67	74.39B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.50	48.97B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.89	47.60B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	16.89	20.17B	16.54B	-1.64B	749.00M	-1.45

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-25	Upgrade	Truist	Sell → Hold
Aug-13-24	Downgrade	Truist	Buy → Sell
Aug-12-24	Downgrade	JP Morgan	Overweight → Underweight
Aug-12-24	Downgrade	Piper Sandler	Overweight → Neutral
Aug-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Aug-12-24	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-03-24	Downgrade	Barclays	Overweight → Equal Weight
Mar-07-24	Resumed	JP Morgan	Overweight
Dec-20-23	Initiated	Raymond James	Outperform
Aug-03-23	Upgrade	TD Cowen	Market Perform → Outperform
Jan-31-23	Resumed	Wedbush	Outperform
Oct-21-22	Resumed	Jefferies	Buy
Jan-03-22	Resumed	JP Morgan	Overweight
Jul-26-21	Upgrade	JP Morgan	Neutral → Overweight
Apr-21-21	Resumed	JP Morgan	Neutral
Apr-09-21	Initiated	Berenberg	Buy
Apr-07-21	Resumed	RBC Capital Mkts	Outperform
Feb-11-21	Downgrade	Northland Capital	Outperform → Market Perform
Jan-21-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Sep-21-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-06-20	Reiterated	Needham	Buy
May-27-20	Initiated	Guggenheim	Neutral
Apr-07-20	Initiated	Northland Capital	Outperform
Mar-20-20	Upgrade	SVB Leerink	Mkt Perform → Outperform
Feb-24-20	Reiterated	H.C. Wainwright	Buy
Jan-24-20	Initiated	SunTrust	Buy
Jan-23-20	Initiated	SunTrust	Buy
Nov-06-19	Initiated	BTIG Research	Buy
Jun-11-19	Initiated	Barclays	Overweight
May-06-19	Upgrade	Mizuho	Underperform → Neutral
May-02-19	Upgrade	Stifel	Sell → Hold
Feb-01-19	Downgrade	Mizuho	Neutral → Underperform
Aug-06-18	Downgrade	BofA/Merrill	Buy → Neutral
Apr-09-18	Reiterated	H.C. Wainwright	Buy
Mar-21-18	Reiterated	Mizuho	Neutral
Feb-16-18	Downgrade	Needham	Buy → Hold
Jan-19-18	Initiated	Seaport Global Securities	Buy
Jan-04-18	Reiterated	Canaccord Genuity	Buy
Jan-03-18	Initiated	Leerink Partners	Mkt Perform

View All

Pacira Biosciences Inc Stock (PCRX) Latest News

Jun 17, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 17, 2025

Jun 16, 2025

When the Price of (PCRX) Talks, People Listen - news.stocktradersdaily.com

Jun 16, 2025

Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 15, 2025

Rhumbline Advisers Sells 9,754 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 15, 2025

Jun 14, 2025

GAMMA Investing LLC Grows Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 14, 2025

Jun 13, 2025

Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan - TipRanks

Jun 13, 2025

Jun 12, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 12, 2025

Have Pacira BioSciences Insiders Been Selling Stock? - simplywall.st

Jun 12, 2025

Jun 11, 2025

Pacira (PCRX) Shares Promising Long-Term Data for Osteoarthritis Gene Therapy | PCRX Stock News - GuruFocus

Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data - GlobeNewswire

Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee - Yahoo Finance

Jun 11, 2025

Pacira BioSciences (NASDAQ:PCRX) Seems To Use Debt Quite Sensibly - simplywall.st

Jun 11, 2025

Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025

Jun 08, 2025